AlphaStreet interview with CEO Spiros Jamas

March 2021 - In an interview with AlphaStreet, our CEO Spiros Jamas said oral delivery format not only presents a vast market opportunity but also significantly increases the attractiveness, compliance, and even cost of delivering therapies.

See interview